189 related articles for article (PubMed ID: 14638881)
21. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.
Andersen JB; Engeland A; Owe JF; Gilhus NE
Eur J Neurol; 2010 Dec; 17(12):1445-50. PubMed ID: 20491896
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
[TBL] [Abstract][Full Text] [Related]
23. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.
Robertson NP; Deans J; Compston DA
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):492-6. PubMed ID: 9771771
[TBL] [Abstract][Full Text] [Related]
24. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
[TBL] [Abstract][Full Text] [Related]
25. Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records.
Foldvari A; Kovacs N; Sipos V; Merth G; Vincze F; Szucs M; Sandor J
Wien Klin Wochenschr; 2015 Jun; 127(11-12):459-64. PubMed ID: 25990531
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
[TBL] [Abstract][Full Text] [Related]
27. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
[TBL] [Abstract][Full Text] [Related]
28. Myasthenia gravis: a higher than expected incidence in the elderly.
Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
[TBL] [Abstract][Full Text] [Related]
29. Myasthenia gravis and elderly people.
Schon F; Drayson M; Thompson RA
Age Ageing; 1996 Jan; 25(1):56-8. PubMed ID: 8670530
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology of myasthenia gravis in central and western Virginia.
Phillips LH; Torner JC; Anderson MS; Cox GM
Neurology; 1992 Oct; 42(10):1888-93. PubMed ID: 1407568
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.
Guidetti D; Sabadini R; Bondavalli M; Cavalletti S; Lodesani M; Mantegazza R; Cosi V; Solime F
Eur J Epidemiol; 1998 Jun; 14(4):381-7. PubMed ID: 9690757
[TBL] [Abstract][Full Text] [Related]
32. Nationwide population-based epidemiological study of myasthenia gravis in taiwan.
Lai CH; Tseng HF
Neuroepidemiology; 2010; 35(1):66-71. PubMed ID: 20523074
[TBL] [Abstract][Full Text] [Related]
33. [Late onset forms of myasthenia gravis. Comparison with early-onset myasthenia gravis].
Barbaud A; Carlander B; Pagès M
Rev Neurol (Paris); 2006 Oct; 162(10):990-6. PubMed ID: 17028567
[TBL] [Abstract][Full Text] [Related]
34. Incidence and prevalence of myasthenia gravis in the United States: A claims-based analysis.
Rodrigues E; Umeh E; Aishwarya ; Navaratnarajah N; Cole A; Moy K
Muscle Nerve; 2024 Feb; 69(2):166-171. PubMed ID: 38040629
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.
Cetin H; Fülöp G; Zach H; Auff E; Zimprich F
Wien Klin Wochenschr; 2012 Nov; 124(21-22):763-8. PubMed ID: 23129486
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
[TBL] [Abstract][Full Text] [Related]
37. Mortality and survival in myasthenia gravis: a Danish population based study.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):78-83. PubMed ID: 9436732
[TBL] [Abstract][Full Text] [Related]
38. Incidence of myasthenia gravis in the Emilia-Romagna region: a prospective multicenter study. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.
Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology
Neurology; 1998 Jul; 51(1):255-8. PubMed ID: 9674813
[TBL] [Abstract][Full Text] [Related]
39. Survival and mortality of adult-onset myasthenia gravis in the population of Belgrade, Serbia.
Basta I; PekmezoviĆ T; Peric S; NikoliĆ A; RakoČeviĆ-StojanoviĆ V; SteviĆ Z; LavrniĆ D
Muscle Nerve; 2018 Nov; 58(5):708-712. PubMed ID: 29572981
[TBL] [Abstract][Full Text] [Related]
40. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
